July’s top stories: St Jude-Thoratec’s $3.4bn deal, Abbott buys Tendyne for $250m

Image: An artificial pancreas has been developed to help replace constant glucose monitoring and frequent insulin injections in Type 1 diabetes patients. Photo: courtesy of ratmaner / iStock / Thinkstock.